Filtered By:
Condition: Diabetes
Nutrition: Weight Loss

This page shows you your search results in order of date.

Order by Relevance | Date

Total 3 results found since Jan 2013.

Tropical Travel Trouble 008 Total TB Extravaganza
LITFL • Life in the Fast Lane Medical Blog LITFL • Life in the Fast Lane Medical Blog - Emergency medicine and critical care medical education blog aka Tropical Travel Trouble 008 Peer Reviewer Dr McBride ID physician, Wisconsin TB affects 1/3rd of the population and one patient dies every 20 seconds from TB. Without treatment 50% of pulmonary TB patients will be dead in 5 years. In low to middle income countries both TB and HIV can be ubiquitous, poor compliance can lead to drug resistance and malnourished infants are highly susceptible. TB can be very complex and this post will hopefully give you the backbone to TB m...
Source: Life in the Fast Lane - June 16, 2018 Category: Emergency Medicine Authors: Neil Long Tags: Clinical Cases Tropical Medicine Genexpert meningitis TB TB meningitis Tuberculosis Source Type: blogs

Let’s stop the unnecessary treatment of heart disease
There are many reasons doctors suffer from burnout and compassion fatigue. One of the least-mentioned of these reasons is that much of what we do is so damn unnecessary. In the US, the land of excess everything, caregivers, especially cardiologists, spend most of our time treating human beings that didn’t need to have disease. Let’s be clear and honest: Lifestyle-related disease is largely unnecessary. These days, there is so much unnecessary disease that caregivers, especially cardiologists, rarely see it. We look past the obesity right to the cholesterol number and ECG. And then we pull out the prescription pad for t...
Source: Dr John M - October 3, 2014 Category: Cardiology Authors: Dr John Source Type: blogs

New drugs: Exenatide – an injectable diabetic agent and Denosumab – a monoclonal antibody for postmenopausal osteoporosis
Exanatide (Byetta): the first injectable synthetic analogue of the incretin hormone glucagon-like peptide-1 (GLP-1) note that the glyptins inhibit incretin breakdown and are thus incretin “enhancers” not “mimics” PBS approved for type 2 diabetics as an addition to the combination of metformin and  sulphonylurea to help lower HbA1c below 7% or as dual Rx for those who cannot tolerate metformin or a sulphonylurea. dose: is given bd s/c within 1 hour BEFORE meals starting at 5 mcg per dose which should be at least 6 hours apart after 1 month, dose can be increased to 10mcg bd main adverse effect...
Source: Oz E Medicine - emergency medicine in Australia - December 11, 2010 Category: Emergency Medicine Authors: Gary Tags: new drugs Source Type: blogs